tradingkey.logo

Vivos Therapeutics Inc

VVOS
View Detailed Chart

5.180USD

+0.850+19.63%
Close 08/01, 16:00ETQuotes delayed by 15 min
30.51MMarket Cap
LossP/E TTM

Vivos Therapeutics Inc

5.180

+0.850+19.63%
Intraday
1m
30m
1h
D
W
M
D

Today

+19.63%

5 Days

-1.15%

1 Month

+16.93%

6 Months

+32.82%

Year to Date

+20.75%

1 Year

+146.67%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts
BUY
Current Rating
4.225
Target Price
-18.44%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
6
Median
8
Average
Company name
Ratings
Analysts
Vivos Therapeutics Inc
VVOS
2
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
28
1
2
3
...
24

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(3)
Neutral(3)
Buy(7)
Indicators
Sell(2)
Neutral(3)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
-0.471
Neutral
RSI(14)
54.970
Neutral
STOCH(KDJ)(9,3,3)
34.023
Buy
ATR(14)
0.595
High Vlolatility
CCI(14)
-50.090
Neutral
Williams %R
63.140
Sell
TRIX(12,20)
0.973
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
4.643
Buy
MA10
5.042
Buy
MA20
5.576
Sell
MA50
3.806
Buy
MA100
3.306
Buy
MA200
3.536
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.
Ticker SymbolVVOS
CompanyVivos Therapeutics Inc
CEOMr. R. Kirk Huntsman
Websitehttps://vivos.com/
KeyAI